GSK872 is a classic RIPK3-selective inhibitor with favorable therapeutic effects in ALI, Alzheimer’s disease, acute kidney injury, spinal cord injury, and systemic inflammatory diseases (Cui et al., 2022b; Zhong et al., 2023). Here, RIPK3 is linked to acute respiratory distress syndrome.